PD-L1 expression in breast invasive ductal carcinoma with incomplete pathological response to neoadjuvant chemotherapy.

导出 OA

翻译打印收藏纠错

作者： Ahmad,Alhesa ^[1] ; Heyam,Awad ^[1] ; Sarah,Bloukh ^[1] ; Mahmoud,Al-Balas ^[2] ; Mohammed,El-Sadoni ^[1] ; Duaa,Qattan ^[1] ; Bilal,Azab ^[1] ; Tareq,Saleh ^[3]

作者单位： Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, 54658The University of Jordan, Amman, Jordan. ^[1] Department of General and Specialized Surgery, Faculty of Medicine, 34419The Hashemite University, Zarqa, Jordan. ^[2] Department of Pathology and Cell Biology, 21611Columbia University Irving Medical Center, New York, NY, USA. ^[3] Department of Basic Medical Sciences, Faculty of Medicine, 34419The Hashemite University, Zarqa, Jordan. ^[4]

关键词 breast cancer immunohistochemistry 22C3 pharmDx immunotherapy neoadjuvant chemotherapy overall survival pathological response programmed death-ligand 1 tumor infiltrating lymphocytes

主题词癌, 导管(Carcinoma, Ductal);人类(Humans);肿瘤辅助疗法(Neoadjuvant Therapy)

DOI 10.1177/03946320221078433

PMID 35225058

发布时间 2022-05-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

International journal of immunopathology and pharmacology

3946320221078433页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

PD-L1 expression in breast invasive ductal carcinoma with incomplete pathological response to neoadjuvant chemotherapy.

International journal of immunopathology and pharmacology

相似文献

International journal of immunopathology and pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

PD-L1 expression in breast invasive ductal carcinoma with incomplete pathological response to neoadjuvant chemotherapy.

International journal of immunopathology and pharmacology

相似文献

International journal of immunopathology and pharmacology

相关期刊

检索历史清除